Update: This post was updated March 4, 2022, with more hospitals approved to prescribe the Optune Lua therapy for mesothelioma.

 

Optune Lua, the brand name for Novocure’s tumor treating fields therapy for malignant mesothelioma, continues adding more hospitals to its partner list.

In June of 2021, three more hospitals got approval from their Internal Review Boards to offer patients this therapy. The three are:

  • Onslow Memorial Hospital (Jacksonville, N.C.)
  • Alabama Oncology (Birmingham)
  • Bon Secours Cancer Institute (Mechanicsville, Virginia)

Twelve more were added in September:

  • Idaho Cancer Center (Idaho Falls)
  • Bon Secours St. Mary’s Hospital (Henrico, Virginia)
  • Sidney Kimmel Cancer Center (Sewell, New Jersey)
  • North Memorial Health Cancer Center (Robbinsdale, Minnesota)
  • Marshall University Department of Surgery (Huntington, West Virginia)
  • New Hampshire Oncology and Hematology
  • Solinsky Center for Cancer Care (Manchester, New Hampshire)
  • Payson Center for Cancer Care (Concord, New Hampshire)
  • Baylor Charles A. Sammons Cancer Center (Dallas, Texas)
  • City of Hope National Medical Center (Duarte, California)
  • University of Rochester Medical Center (Rochester, New York)
  • Genesis Cancer Care Center (Zanesville, Ohio)

Then in February of 2022, two hospitals added Optune Lua to their offerings for malignant mesothelioma: Health First Cancer Institute (Titusville, Florida); and University Cancer Center (seven locations in Texas, including Houston).

This brings the total number of hospitals in the United States with Optune Lua to nearly 120. Some of them are separate locations for the same health system, such as Ochsner Hospital’s two locations in Louisiana.

Optune Lua is the branded device delivering tumor treating fields for cancer. It received approval from the U.S. Food and Drug Administration in May 2019 for malignant pleural mesothelioma. Optune Lua is only for unresectable cases of the cancer and must be used with a chemotherapy regimen of cisplatin and pemetrexed.

More than 30 states have a hospital offering this unique therapy. Some of the top-ranked mesothelioma cancer centers offering Optune Lua are:

Optune Lua sends electromagnetic waves through the patient’s body. These waves disrupt cancer cell replication and halt the growth of tumors. Optune Lua has a 97% disease‑response rate, meaning there’s a positive reaction for the patient to this therapy.

If you are seeking medical care for your mesothelioma cancer, we can help. Contact our registered nurse, Karen Ritter, at karen@mesotheliomaguide.com. She can help you start Optune Lua therapy or another treatment to begin fighting your tumors.

Guide Packet Desktop Ad

Want to learn more?

Try Our Free Guide to Fighting Mesothelioma

Get in depth knowledge about your diagnosis & the best treatments.

Learn More
Guide Packet Mobile Ad

    Sources & Author

Picture of Devin Golden

About the Writer, Devin Golden

Devin Golden is the content writer for Mesothelioma Guide. He produces mesothelioma-related content on various mediums, including the Mesothelioma Guide website and social media channels. Devin's objective is to translate complex information regarding mesothelioma into informative, easily absorbable content to help patients and their loved ones.